U.S. Other Utilities Stock News

Yum China Holdings (YUMC) is back in focus after research firm Zacks highlighted the company’s 17.1% expected earnings growth rate for the current year and its current Zacks Rank #2 rating. See our latest analysis for Yum China Holdings. Yum China Holdings’ recent 1-day share price return of 1.52% and 1-month share price return of 4.55% come after a period where the year to date share price return declined 9.86% and the 1-year total shareholder return declined 9.52%. This suggests short term...

Avista stock has delivered a 24.8% total return over the past three years, and at a recent price of US$42.23 the valuation picture is now mixed, with the Dividend Discount Model (DDM) suggesting a premium to its intrinsic value while market based multiples look closer to fair value. Over the last 3 years Avista has returned 24.8%. This puts more focus on whether that performance is already fully reflected in the current share price. For income focused investors, the stability of Avista's...

Impact of Syntetica Funding on lululemon athletica Stock Lululemon athletica (LULU) has joined a $30 million Series A round for French recycler Syntetica, backing technology aimed at processing mixed post consumer nylon waste into reusable material for textiles. The funding will help Syntetica build its first commercial demonstration facility, a step that ties lululemon athletica more closely to nylon recycling efforts that could interest investors focused on supply chain and materials...

Virtu Financial’s latest quarterly figures Virtu Financial (VIRT) stock is in focus after the company released second quarter 2026 results and related guidance, including net income of $285 million and basic and diluted earnings per share of $1.63. The company reported revenue of $1,190 million for the quarter ended June 30, 2026, compared with $1,000 million in the same period a year earlier. Net income was $285 million, compared with $293 million a year ago. See our latest analysis for...

Toast stock sits at the center of a valuation tug of war, with the Excess Returns intrinsic value estimate pointing to meaningful upside, while traditional market multiples make the shares look expensive after a year in which the price has declined sharply. Over the past 12 months, Toast has fallen 38.4%, which puts recent enthusiasm around the stock in the context of a still weak one year return profile. Goldman Sachs' upgrade, tied to Toast's AI driven tools and expanding restaurant...

In recent days, ExxonMobil has drawn attention as investors looked ahead to its July 31, 2026 earnings release, supported by firm crude prices amid renewed U.S.–Iran tensions and Middle East supply concerns. A key angle for investors is how expectations for a very large year-over-year earnings rebound intersect with geopolitically driven oil price strength, potentially amplifying perceptions of ExxonMobil’s cash-generation power and resilience. With this backdrop of oil-price support from...

Fastenal stock has delivered an 88.3% return over the past five years, yet recent valuation checks and market multiples point to a setup where the shares may be pricing in a lot of good news already rather than offering an obvious bargain. Fastenal's 88.3% gain over five years highlights that long term holders have already seen substantial value creation, which can raise the bar for future returns from today's price. Ongoing investment in digital and inventory management services may support...

Penumbra (NYSE:PEN) reported key clinical results from its THUNDER study, indicating the THUNDERBOLT stroke treatment system met safety and effectiveness goals. The THUNDERBOLT system has now seen its first clinical use following recent FDA clearance, with initial adoption at a leading neuroscience institute. These updates add new clinical and real-world data points beyond prior announcements on the FORWARD study and regulatory clearance. For investors tracking Penumbra, the THUNDERBOLT...

Earlier this week, electronic components manufacturer Knowles (NYSE:KN) reported quarterly results following its prior period of year-on-year revenue growth, when it exceeded analysts’ expectations for both revenue and earnings per share and guided above consensus for the subsequent quarter. With the market currently expecting another year-on-year revenue increase roughly in line with last year’s pace, investor attention is firmly on whether Knowles can extend this recent pattern of...

Earlier this week, Rocket Lab confirmed it had secured a US$266 million firm-fixed-price contract from the U.S. Air Force and U.S. Space Force for 12 suborbital launches, with options for six additional missions through 2028 using its Electron and HASTE vehicles from the Pacific Spaceport Complex in Alaska. This long-term government launch award deepens Rocket Lab’s role in U.S. national security space programs and adds multi-year revenue visibility that can support capital-intensive...

Rollins (ROL) moved back into the spotlight after its second quarter 2026 earnings, as the pest control company reported modestly higher net income and earnings per share compared with the same period last year. See our latest analysis for Rollins. The latest earnings miss and the recent dividend declaration came against a weak share price backdrop, with Rollins trading at US$43.47 after a 90 day share price return that fell 23.72%, while the 5 year total shareholder return of 25.90% shows a...

We wouldn't blame Accelerant Holdings ( NYSE:ARX ) shareholders if they were a little worried about the fact that...

Over the last 7 days, the United States market has experienced a 1.4% drop, yet it remains up by 16% over the past year with earnings forecast to grow by 18% annually. In this context, identifying stocks that are potentially undervalued can be appealing for investors seeking opportunities in small-cap companies where insider buying might indicate confidence in future performance.

Over the last 7 days, the United States market has dropped 1.4%, but it remains up by 16% over the past year, with earnings expected to grow by 18% per annum in the coming years. In this dynamic environment, a good high-growth tech stock may be characterized by its potential for expansion and innovation, aligning well with current market conditions that favor robust earnings growth.

Over the last 7 days, the United States market has experienced a 1.4% decline, yet it remains up by 16% over the past year with earnings expected to grow by 18% annually. In this fluctuating environment, identifying stocks that may be priced below their estimated value can offer potential opportunities for investors seeking to capitalize on market inefficiencies.

Over the last 7 days, the United States market has experienced a 1.4% drop, yet it remains up by 16% over the past year with earnings projected to grow by 18% annually. In this context, growth companies with significant insider ownership can be particularly appealing as they often signal strong internal confidence and alignment of interests between management and shareholders.

Over the last 7 days, the United States market has dropped 1.4%, but it has risen by 16% over the past year, with earnings forecasted to grow annually by 18%. In such a dynamic market, identifying stocks that combine affordability with growth potential is key, especially when they boast strong financials. Penny stocks may seem like a term from another era, yet they continue to offer unique opportunities for investors seeking growth in smaller or newer companies.

The United States market has experienced a 1.4% decline over the last week, yet it remains up by 16% over the past year with earnings projected to grow by 18% annually. In this context, identifying strong dividend stocks can be an effective strategy for investors seeking steady income and potential growth amidst fluctuating market conditions.

Consensus Cloud Solutions, Inc. ( NASDAQ:CCSI ), might not be a large cap stock, but it saw a significant share price...

Tariffs of at least 10% on imported consumer goods are set to reshuffle costs across retail, and investors are already weighing which stocks could feel more pressure from global supply chains and which might be relatively cushioned. The US Retailers with Predominantly Domestic Supply Chains screener focuses on companies with strong balance sheets and a heavier tilt toward home markets, a profile that may matter more as new Section 301 measures take effect. This article looks at three stocks...

Boston Scientific (NYSE:BSX) has enrolled the first patient in the FARADIGM global IDE trial for its Faraflex pulsed field ablation catheter. The FARADIGM study is designed to evaluate the Faraflex PFA system for the treatment of atrial fibrillation. This is a new global clinical program focused on cardiac rhythm management and catheter based ablation. For investors tracking Boston Scientific, the first patient enrollment in the FARADIGM IDE trial represents a new development in its cardiac...

Kenneth S. Booth’s resignation from the board of Credit Acceptance (CACC) on July 21, 2026, and the reduction of the board to five directors, gives investors fresh context for assessing the stock. See our latest analysis for Credit Acceptance. Alongside Kenneth S. Booth’s exit, Credit Acceptance’s recent share price moves tell a story of solid momentum, with the stock down 1.98% over one day but showing a 30-day share price return of 4.97%, a 90-day share price return of 17.09%, and a 1-year...

Former SentinelOne (NYSE:S) founders have launched Neo, a startup focused on securing AI agents used inside enterprises. Neo is developing tools to monitor and control AI agents that act with real employee credentials within business software. The move highlights a security gap where AI agents may operate outside traditional identity and endpoint protections used by companies like SentinelOne. For investors following SentinelOne at a share price of $18.22, the launch of Neo by its former...

Morgan Stanley's downgrade of Salesforce (CRM), driven by slower than expected progress in turning Agentforce and other AI efforts into organic growth while legacy units drag on performance, has sharpened questions about how the stock is currently priced. See our latest analysis for Salesforce. The 1 day share price decline of 4.15% to US$163 and recent analyst downgrades sit against a mixed backdrop. The 30 day share price return is 8.58%, but year to date share price and 1 year total...